These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25820351)

  • 1. Selective serotonin reuptake inhibitors and β-blocker transformation products may not pose a significant risk of toxicity to aquatic organisms in wastewater effluent-dominated receiving waters.
    Brown AK; Challis JK; Wong CS; Hanson ML
    Integr Environ Assess Manag; 2015 Oct; 11(4):618-39. PubMed ID: 25820351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: a case study including a cocktail scenario.
    Styrishave B; Halling-Sørensen B; Ingerslev F
    Environ Toxicol Chem; 2011 Jan; 30(1):254-61. PubMed ID: 20928917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global scanning of selective serotonin reuptake inhibitors: occurrence, wastewater treatment and hazards in aquatic systems.
    Mole RA; Brooks BW
    Environ Pollut; 2019 Jul; 250():1019-1031. PubMed ID: 31085468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of wastewater treatment plants on receiving surface waters and a tentative risk evaluation: the case of estrogens and beta blockers.
    Gabet-Giraud V; Miège C; Jacquet R; Coquery M
    Environ Sci Pollut Res Int; 2014 Feb; 21(3):1708-1722. PubMed ID: 23975711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
    Henry TB; Kwon JW; Armbrust KL; Black MC
    Environ Toxicol Chem; 2004 Sep; 23(9):2229-33. PubMed ID: 15379001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.
    Johnson DJ; Sanderson H; Brain RA; Wilson CJ; Bestari KJ; Solomon KR
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):313-23. PubMed ID: 16024151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspect and non-target screening of pesticides and pharmaceuticals transformation products in wastewater using QTOF-MS.
    Wang X; Yu N; Yang J; Jin L; Guo H; Shi W; Zhang X; Yang L; Yu H; Wei S
    Environ Int; 2020 Apr; 137():105599. PubMed ID: 32109725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae.
    Johnson DJ; Sanderson H; Brain RA; Wilson CJ; Solomon KR
    Ecotoxicol Environ Saf; 2007 May; 67(1):128-39. PubMed ID: 16753215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
    Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
    J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hazard screening of photo-transformation products from pharmaceuticals: Application to selective β
    Toolaram AP; Menz J; Rastogi T; Leder C; Kümmerer K; Schneider M
    Sci Total Environ; 2017 Feb; 579():1769-1780. PubMed ID: 27939084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation and localization of beta-blockers and SSRIs accumulation in fathead minnows by complementary mass spectrometry analyses.
    Davis RB; Hoang JA; Rizzo SM; Hassan D; Potter BJ; Tucker KR
    Sci Total Environ; 2020 Nov; 741():140331. PubMed ID: 32615427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework.
    Oakes KD; Coors A; Escher BI; Fenner K; Garric J; Gust M; Knacker T; Küster A; Kussatz C; Metcalfe CD; Monteiro S; Moon TW; Mennigen JA; Parrott J; Péry AR; Ramil M; Roennefahrt I; Tarazona JV; Sánchez-Argüello P; Ternes TA; Trudeau VL; Boucard T; Van Der Kraak GJ; Servos MR
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():524-39. PubMed ID: 20821717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering transformation products of four organic contaminants of concern by photodegradation experiments and analysis of real samples from a local river.
    Eysseric E; Gagnon C; Segura PA
    Chemosphere; 2022 Apr; 293():133408. PubMed ID: 34968520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol.
    Küster A; Alder AC; Escher BI; Duis K; Fenner K; Garric J; Hutchinson TH; Lapen DR; Péry A; Römbke J; Snape J; Ternes T; Topp E; Wehrhan A; Knacker T
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():514-23. PubMed ID: 19886730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering transformation products of pharmaceuticals in domestic wastewaters and receiving rivers by using non-target screening and machine learning approaches.
    Han Y; Hu LX; Liu T; Dong LL; Liu YS; Zhao JL; Ying GG
    Sci Total Environ; 2024 Oct; 948():174715. PubMed ID: 39002592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental risk assessment of psychoactive drugs in the aquatic environment.
    Cunha DL; Mendes MP; Marques M
    Environ Sci Pollut Res Int; 2019 Jan; 26(1):78-90. PubMed ID: 30397754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixture and single-substance acute toxicity of selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
    Henry TB; Black MC
    Environ Toxicol Chem; 2007 Aug; 26(8):1751-5. PubMed ID: 17702351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one-year follow-up analysis of antidepressants in Portuguese wastewaters: occurrence and fate, seasonal influence, and risk assessment.
    Silva LJ; Pereira AM; Meisel LM; Lino CM; Pena A
    Sci Total Environ; 2014 Aug; 490():279-87. PubMed ID: 24858225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-blockers in the environment: Distribution, transformation, and ecotoxicity.
    Yi M; Sheng Q; Sui Q; Lu H
    Environ Pollut; 2020 Nov; 266(Pt 2):115269. PubMed ID: 32836046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.